Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)
10.49
-0.41 (-3.76%)
Nov 13, 2026, 3:00 PM CST
| Market Cap | 4.19B -16.5% |
| Revenue (ttm) | 1.64B -5.7% |
| Net Income | 52.84M -67.1% |
| EPS | 0.13 -68.2% |
| Shares Out | 399.65M |
| PE Ratio | 82.46 |
| Forward PE | n/a |
| Dividend | 0.06 (0.57%) |
| Ex-Dividend Date | Jun 30, 2026 |
| Volume | 10,431,595 |
| Open | 10.91 |
| Previous Close | 10.90 |
| Day's Range | 10.43 - 10.95 |
| 52-Week Range | 9.51 - 17.46 |
| Beta | 1.06 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 28, 2026 |